top of page
Accelerating next-gen sequencing & diagnostics
INVESTMENt
October, 2018
Sector
Science
FUND
Fund 1
location
Southern California
co-investors
Mount Wilson Ventures
Embark Ventures
InAmerica Ventures
Quintuple aim
SeqOnce is accelerating life science discoveries and improving patient outcomes by focusing on Next-Gen Sequencing for genomics and diagnostics. SeqOnce’s proprietary technology uses a unique set of enzymatic reactions to reduce reaction steps and reagents. The result is a sample library prep kit that is fast, easy to use, and produces high-quality libraries regardless of sample source or application.
bottom of page